Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Translocation (11;22) in Ewing's sarcoma.

F Prieto, L Badía, J Montalar

    Cancer Genetics and Cytogenetics
    |May 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025
    Same author

    Multiplexed therapeutic drug monitoring (TDM) of antiviral drugs by LC-MS/MS.

    Clinical mass spectrometry (Del Mar, Calif.)·2024
    Same author

    Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer-final results of the EUCROSS trial.

    ESMO open·2024
    Same author

    A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2021
    Same author

    First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).

    BMC cancer·2019
    Same author

    Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy.

    Annals of oncology : official journal of the European Society for Medical Oncology·2019

    A cytogenetic study found a specific chromosomal translocation, t(11;22), in Ewing's sarcoma tumor cells. This finding confirms the translocation is inherent to the cancer, not an artifact of lab conditions.

    Area of Science:

    • Cytogenetics
    • Oncology
    • Molecular Biology

    Background:

    • Ewing's sarcoma is a rare bone and soft tissue cancer.
    • Cytogenetic abnormalities are crucial for understanding cancer development.
    • The t(11;22) translocation is a known hallmark of Ewing's sarcoma.

    Observation:

    • A direct cytogenetic method was applied to a patient's Ewing's sarcoma tumor.
    • The study analyzed six tumor cells using this direct method.
    • A specific structural alteration, the t(11;22) translocation, was identified.

    Findings:

    • The t(11;22) translocation was consistently observed in all analyzed tumor cells.
    • Detection via direct method confirms the translocation is an intrinsic feature of Ewing's sarcoma.

    Related Experiment Videos

  • This validates that the translocation is not induced by cell culture conditions.

    • Implications:

    • Reinforces the t(11;22) translocation as a reliable diagnostic marker for Ewing's sarcoma.
    • Supports the use of direct cytogenetic analysis for accurate cancer characterization.
    • Provides evidence against artifactual origins of this key genetic alteration in cancer research.